Until Nasdaq starts moving forward, no one expects anything.
Semiconductors are not what the market wants to see right now.
Since we're coming out of a gap, we would like to see the deals stick with their price ranges. This would show they didn't lower their terms to get the institutions to bite.
Odyssey is in wait-and-see mode. It's kind of unknown what the institutional demand will be.
For the size of the deal, it did fantastic. That's a huge deal so to get any sort of price movement is great.
Given the skittishness I would imagine a lot of investors would welcome this.
If we see more techs do well this will provide some sort of a footing for the IPO market.
It is an NYSE deal and of course you don't expect to see a lot of jump with those.
Just because of Andreessen, this will get institutions interested.
With 360 million shares you have to (have a huge sales force).
This will be very interesting to watch. B2C is still very much out of favor.
Underwriters are very careful now in how they bring their deals out. They're just waiting for the opportunity to bring their deals forward.
Every year the IPO market gets off to a slow start, and given last year's performance, it should get off to an even slower start this year.
Technology had a reasonably good run on the Nasdaq last weekend, but once again it's really wait and see how they price.
AFC is as far away from high tech as you can get. At the moment that's a good thing.
This is a real company, with a real product and real services. This isn't a speculative deal like a dot.com.
This is an example of a pretty good brand name. It just wasn't interesting.
This is not a good time right now for Nextel to come out.
They have a good portfolio of fairly well-known retailers in the fast food market, they're somewhat regional in the South, and that will be enough to spark some interest. But it's not a deal that will see any sort of price movement.
They are coming out at the right time in the market.
They're a very solid company and it looks like they're getting good demand.
It's a totally different kind of deal. It's not a high-tech company and that's kind of a good thing.
Food safety is always of interest to the consumer.
It's too early for a rebound though, and the market is still very selective.
Considering the economy, a lot of people are doing mid-career retraining.
It will be interesting to see if an online retailer can come into this market and get a good response. Everyone's heard of them but the question is whether they'll get the attention of the Street.
After the genomic (breakthrough) biotech in general has been doing really well.
Exact did have to price at bottom of the range, but at least they didn't have to cut.
The interesting thing is that they seem to be developing pretty decent brand recognition among consumers. It does show that there is some demand for more non-infrastructure issues.
Institutions are always interested in hearing about these sorts of deal. They could do reasonably well and see a moderate pop.
It has to do more with the standard of living than anything else. As the standard of living keeps growing, more people can afford these services, but how fast they will grow in China is anyone's guess.
It has created the type of publicity that a good IPO needs.
The market for tech deals is sort of on-again, off-again, so you've got to look at the fundamentals that they have decent revenue for a company this size.
The human capital sector is very hot. But . . . the market may value this deal as a consulting firm instead of a human capital firm. That's just not the best sector right now. People have the perspective that it's not the most profitable industry.
The dynamics of an IPO, especially one with the hype like this one, is always hard to predict right out of the gate. But this is a great company. It's one a lot of institutions are going to want to invest in.
The market is so cautious right now and so shaky that if you don't have all those perfect scenarios, then you will trade at your IPO price.
The main thing I'm looking at is I expect this to stay on the calendar. If it were a high-tech company it would be up in the air.
